Literature DB >> 25710192

Structural basis of activity against aztreonam and extended spectrum cephalosporins for two carbapenem-hydrolyzing class D β-lactamases from Acinetobacter baumannii.

Joshua M Mitchell, Jozlyn R Clasman, Cynthia M June, Kip-Chumba J Kaitany, James R LaFleur, Magdalena A Taracila1, Neil V Klinger, Robert A Bonomo1, Troy Wymore2, Agnieszka Szarecka, Rachel A Powers, David A Leonard.   

Abstract

The carbapenem-hydrolyzing class D β-lactamases OXA-23 and OXA-24/40 have emerged worldwide as causative agents for β-lactam antibiotic resistance in Acinetobacter species. Many variants of these enzymes have appeared clinically, including OXA-160 and OXA-225, which both contain a P → S substitution at homologous positions in the OXA-24/40 and OXA-23 backgrounds, respectively. We purified OXA-160 and OXA-225 and used steady-state kinetic analysis to compare the substrate profiles of these variants to their parental enzymes, OXA-24/40 and OXA-23. OXA-160 and OXA-225 possess greatly enhanced hydrolytic activities against aztreonam, ceftazidime, cefotaxime, and ceftriaxone when compared to OXA-24/40 and OXA-23. These enhanced activities are the result of much lower Km values, suggesting that the P → S substitution enhances the binding affinity of these drugs. We have determined the structures of the acylated forms of OXA-160 (with ceftazidime and aztreonam) and OXA-225 (ceftazidime). These structures show that the R1 oxyimino side-chain of these drugs occupies a space near the β5-β6 loop and the omega loop of the enzymes. The P → S substitution found in OXA-160 and OXA-225 results in a deviation of the β5-β6 loop, relieving the steric clash with the R1 side-chain carboxypropyl group of aztreonam and ceftazidime. These results reveal worrying trends in the enhancement of substrate spectrum of class D β-lactamases but may also provide a map for β-lactam improvement.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25710192      PMCID: PMC4476283          DOI: 10.1021/bi501547k

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  50 in total

1.  Laboratory mutants of OXA-10 beta-lactamase giving ceftazidime resistance in Pseudomonas aeruginosa.

Authors:  F Danel; L M Hall; D M Livermore
Journal:  J Antimicrob Chemother       Date:  1999-03       Impact factor: 5.790

2.  Evolution of an antibiotic resistance enzyme constrained by stability and activity trade-offs.

Authors:  Xiaojun Wang; George Minasov; Brian K Shoichet
Journal:  J Mol Biol       Date:  2002-06-28       Impact factor: 5.469

3.  Identification of diverse OXA-40 group carbapenemases, including a novel variant, OXA-160, from Acinetobacter baumannii in Pennsylvania.

Authors:  Guo-Bao Tian; Jennifer M Adams-Haduch; Tatiana Bogdanovich; Anthony W Pasculle; John P Quinn; Hong-Ning Wang; Yohei Doi
Journal:  Antimicrob Agents Chemother       Date:  2010-11-01       Impact factor: 5.191

Review 4.  CHARMM: the biomolecular simulation program.

Authors:  B R Brooks; C L Brooks; A D Mackerell; L Nilsson; R J Petrella; B Roux; Y Won; G Archontis; C Bartels; S Boresch; A Caflisch; L Caves; Q Cui; A R Dinner; M Feig; S Fischer; J Gao; M Hodoscek; W Im; K Kuczera; T Lazaridis; J Ma; V Ovchinnikov; E Paci; R W Pastor; C B Post; J Z Pu; M Schaefer; B Tidor; R M Venable; H L Woodcock; X Wu; W Yang; D M York; M Karplus
Journal:  J Comput Chem       Date:  2009-07-30       Impact factor: 3.376

5.  A case of IMP-4-, OXA-421-, OXA-96-, and CARB-2-producing Acinetobacter pittii sequence type 119 in Australia.

Authors:  Witchuda Kamolvit; Petra Derrington; David L Paterson; Hanna E Sidjabat
Journal:  J Clin Microbiol       Date:  2014-11-26       Impact factor: 5.948

6.  Three factors that modulate the activity of class D β-lactamases and interfere with the post-translational carboxylation of Lys70.

Authors:  Lionel Vercheval; Cédric Bauvois; Alexandre di Paolo; Franck Borel; Jean-Luc Ferrer; Eric Sauvage; André Matagne; Jean-Marie Frère; Paulette Charlier; Moreno Galleni; Frédéric Kerff
Journal:  Biochem J       Date:  2010-12-15       Impact factor: 3.857

7.  Acyl-intermediate structures of the extended-spectrum class A beta-lactamase, Toho-1, in complex with cefotaxime, cephalothin, and benzylpenicillin.

Authors:  Tatsuro Shimamura; Akiko Ibuka; Shinya Fushinobu; Takayoshi Wakagi; Masaji Ishiguro; Yoshikazu Ishii; Hiroshi Matsuzawa
Journal:  J Biol Chem       Date:  2002-09-08       Impact factor: 5.157

8.  Structures of the class D Carbapenemases OXA-23 and OXA-146: mechanistic basis of activity against carbapenems, extended-spectrum cephalosporins, and aztreonam.

Authors:  Kip-Chumba J Kaitany; Neil V Klinger; Cynthia M June; Maddison E Ramey; Robert A Bonomo; Rachel A Powers; David A Leonard
Journal:  Antimicrob Agents Chemother       Date:  2013-07-22       Impact factor: 5.191

9.  MolProbity: all-atom structure validation for macromolecular crystallography.

Authors:  Vincent B Chen; W Bryan Arendall; Jeffrey J Headd; Daniel A Keedy; Robert M Immormino; Gary J Kapral; Laura W Murray; Jane S Richardson; David C Richardson
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2009-12-21

10.  Phaser crystallographic software.

Authors:  Airlie J McCoy; Ralf W Grosse-Kunstleve; Paul D Adams; Martyn D Winn; Laurent C Storoni; Randy J Read
Journal:  J Appl Crystallogr       Date:  2007-07-13       Impact factor: 3.304

View more
  10 in total

1.  The structure of a doripenem-bound OXA-51 class D β-lactamase variant with enhanced carbapenemase activity.

Authors:  Cynthia M June; Taylor J Muckenthaler; Emma C Schroder; Zachary L Klamer; Zdzislaw Wawrzak; Rachel A Powers; Agnieszka Szarecka; David A Leonard
Journal:  Protein Sci       Date:  2016-09-26       Impact factor: 6.725

2.  Kinetic characterization of GES-22 β-lactamase harboring the M169L clinical mutation.

Authors:  Aysegul Saral; David A Leonard; Azer Ozad Duzgun; Aysegul Copur Cicek; Cynthia M June; Cemal Sandalli
Journal:  J Antibiot (Tokyo)       Date:  2016-05-11       Impact factor: 2.649

3.  Genetic and biochemical characterization of OXA-405, an OXA-48-type extended-spectrum β-lactamase without significant carbapenemase activity.

Authors:  Laurent Dortet; Saoussen Oueslati; Katy Jeannot; Didier Tandé; Thierry Naas; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2015-04-13       Impact factor: 5.191

4.  Clinical Variants of the Native Class D β-Lactamase of Acinetobacter baumannii Pose an Emerging Threat through Increased Hydrolytic Activity against Carbapenems.

Authors:  Emma C Schroder; Zachary L Klamer; Aysegul Saral; Kyle A Sugg; Cynthia M June; Troy Wymore; Agnieszka Szarecka; David A Leonard
Journal:  Antimicrob Agents Chemother       Date:  2016-09-23       Impact factor: 5.191

5.  Multiple substitutions lead to increased loop flexibility and expanded specificity in Acinetobacter baumannii carbapenemase OXA-239.

Authors:  Thomas M Harper; Cynthia M June; Magdalena A Taracila; Robert A Bonomo; Rachel A Powers; David A Leonard
Journal:  Biochem J       Date:  2018-01-11       Impact factor: 3.857

Review 6.  β-Lactam antibiotic targets and resistance mechanisms: from covalent inhibitors to substrates.

Authors:  Montserrat Mora-Ochomogo; Christopher T Lohans
Journal:  RSC Med Chem       Date:  2021-08-04

7.  Intrinsic Class D β-Lactamases of Clostridium difficile.

Authors:  Marta Toth; Nichole K Stewart; Clyde Smith; Sergei B Vakulenko
Journal:  mBio       Date:  2018-12-18       Impact factor: 7.867

8.  Structural Analysis of The OXA-48 Carbapenemase Bound to A "Poor" Carbapenem Substrate, Doripenem.

Authors:  Krisztina M Papp-Wallace; Vijay Kumar; Elise T Zeiser; Scott A Becka; Focco van den Akker
Journal:  Antibiotics (Basel)       Date:  2019-09-11

9.  Arginine Modulates Carbapenem Deactivation by OXA-24/40 in Acinetobacter baumannii.

Authors:  Jamie VanPelt; Shannon Stoffel; Michael W Staude; Kayla Dempster; Heath A Rose; Sarah Graney; Erin Graney; Sara Braynard; Elizaveta Kovrigina; David A Leonard; Jeffrey W Peng
Journal:  J Mol Biol       Date:  2021-07-14       Impact factor: 6.151

10.  A gratuitous β-Lactamase inducer uncovers hidden active site dynamics of the Staphylococcus aureus BlaR1 sensor domain.

Authors:  Thomas E Frederick; Jeffrey W Peng
Journal:  PLoS One       Date:  2018-05-17       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.